← Back to Search

Ultrasound and Biopsy for Endometrial Hyperplasia

N/A
Waitlist Available
Led By Richard Legro, M.D.
Research Sponsored by Milton S. Hershey Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Postmenopausal obese subjects, who have diabetes or a prediabetic state, or hypertension
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of study
Awards & highlights
No Placebo-Only Group

Summary

The investigators hypothesize that endometrial thickness will be a significant predictor of endometrial hyperplasia in a postmenopausal female population with metabolic syndrome: diabetes and/or insulin resistance, hypertension, and obesity.

Eligible Conditions
  • Endometrial Hyperplasia

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of study
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of study for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Endometrial Hyperplasia
Secondary study objectives
Endometrial Cancer

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Ultrasound and BiopsyExperimental Treatment1 Intervention
Transvaginal Ultrasound and Endometrial Biopsy

Find a Location

Who is running the clinical trial?

Center for Research on Women and HealthUNKNOWN
Milton S. Hershey Medical CenterLead Sponsor
510 Previous Clinical Trials
2,796,413 Total Patients Enrolled
1 Trials studying Endometrial Hyperplasia
Richard Legro, M.D.Principal InvestigatorPenn State College of Medicine
5 Previous Clinical Trials
232 Total Patients Enrolled
1 Trials studying Endometrial Hyperplasia
~2 spots leftby Dec 2025